NORML
APRIL 8, 2020
As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received. In 2007, the agency lost yet another lawsuit.
NORML
JANUARY 17, 2019
As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” The agency ultimately rejected her decision.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
MARCH 1, 2019
” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. .”
Cannabis Law Report
JANUARY 5, 2022
In 2011, Levine was arrested along with five others after they planted hemp seeds on the lawn at the DEA headquarters in Arlington, VA. 2009 ~ DEA Headquarters ~ American Farmers Shall Grow Hemp Again, Reefer Madness Will Be Buried.”
Cannabis Law Report
FEBRUARY 10, 2022
Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.
Otherside Farms
JANUARY 10, 2021
However, in 2004, there was a lawsuit against the Hemp Industries Association and the DEA. In 2007, some farmers in North Dakota actually received a hemp license, and they were allowed to grow hemp. Since there was none being grown locally, they had to import it so they could avoid a shortage.
Otherside Farms
MAY 9, 2022
Japanese researchers published a paper in 2007 describing HHC’s impressive pain-blocking capability in mice. HHC could get the attention of the Drug Enforcement Administration (DEA) as some experts think HHC falls under the Federal Analogue Act, which automatically classifies analogs of Schedule 1 drugs as Schedule 1 drugs. percent.
Expert insights. Personalized for you.
351 
Let's personalize your content